Steffen Durinck
- Molecular Biology top 2%
- Cancer Research top 2%
- Genetics top 2%
- Immunology top 5%
- Oncology top 5%
- Co-authors
- Wolfgang HuberPaul T. SpellmanEwan BirneyAlvis BrāzmaYves MoreauSean DavisBart De MoorA. Kasprzyk
- Topics
- Gene expression and cancer classification (9 papers)Genomics and Phylogenetic Studies (6 papers)CRISPR and Genetic Engineering (5 papers)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Steffen Durinck
31 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Molecular Biology 3.2k
- Cancer Research 990
- Genetics 914
- Immunology 590
- Oncology 464
Countries citing papers authored by Steffen Durinck
This map shows the geographic impact of Steffen Durinck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffen Durinck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffen Durinck more than expected).
Fields of papers citing papers by Steffen Durinck
This network shows the impact of papers produced by Steffen Durinck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffen Durinck. The network helps show where Steffen Durinck may publish in the future.
Co-authorship network of co-authors of Steffen Durinck
This figure shows the co-authorship network connecting the top 25 collaborators of Steffen Durinck. A scholar is included among the top collaborators of Steffen Durinck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steffen Durinck. Steffen Durinck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 2 | |
| 3 | 9 | |
| 4 | 7 | |
| 5 | 23 | |
| 6 | 17 | |
| 7 | 9 | |
| 8 | 47 | |
| 9 | 5 | |
| 10 | 52 | |
| 11 | 181 | |
| 12 | 31 | |
| 13 | 44 | |
| 14 | 51 | |
| 15 | Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRtbreakdown → | 2361 |
| 16 | 11 | |
| 17 | 232 | |
| 18 | 20 | |
| 19 | BioMart and Bioconductor: a powerful link between biological databases and microarray data analysisbreakdown → | 1376 |
| 20 | 94 |
About Steffen Durinck
Steffen Durinck is a scholar working on Molecular Biology, Cancer Research and Oncology, having authored 32 papers that have together received 5.0k indexed citations. Recurring topics across this work include Gene expression and cancer classification (9 papers), Genomics and Phylogenetic Studies (6 papers) and CRISPR and Genetic Engineering (5 papers). The work is most often cited by research in Cancer Research (990 citations), Molecular Biology (3.2k citations) and Aging (66 citations). Steffen Durinck has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Wolfgang Huber, Paul T. Spellman, Ewan Birney, Alvis Brāzma, Yves Moreau, Sean Davis, Bart De Moor, A. Kasprzyk, Adam Cheuk and Young Song. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.